These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3289432)

  • 1. The treatment of chronic type B viral hepatitis.
    Aach RD
    Ann Intern Med; 1988 Jul; 109(2):89-91. PubMed ID: 3289432
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
    Brook MG
    Lancet; 1988 Oct; 2(8618):1017-8. PubMed ID: 2902445
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon in chronic hepatitis B.
    Gregory PB
    Gastroenterology; 1986 Jan; 90(1):237-40. PubMed ID: 3940248
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracorporeal immunomodulation in chronic hepatitis type B with double filtration plasmapheresis.
    Fujikawa M; Tomita A; Nakata S; Matuura Y; Azechi H; Saibara T; Onishi S; Yamamoto Y
    Prog Clin Biol Res; 1990; 337():341-4. PubMed ID: 2352990
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
    Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
    J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha interferon therapy in patients with hepatitis infection undergoing organ transplantation.
    Mancini C; Gaeta A; Lorino G; Filadoro F; Marinucci G; Bachetoni A; Pretagostini R; Molajoni ER; Alfani D; Cortesini R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2429-30. PubMed ID: 2652794
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.
    McDonald EM; Mann AH; Thomas HC
    Lancet; 1987 Nov; 2(8569):1175-8. PubMed ID: 2890808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
    Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
    Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
    Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
    Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of hepatitis B virus carrier state with nephrotic syndrome treated with beta interferon].
    Kawarazaki N; Sano K; Hayashishita N; Mitani S; Saga M; Karino Y; Sugawara S; Yoshida J; Matsushima T; Miyazaki T
    Nihon Naika Gakkai Zasshi; 1990 May; 79(5):682-3. PubMed ID: 2380616
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
    Anderson MG; Harrison TJ; Alexander GJ; Zuckerman AJ; Murray-Lyon IM
    J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 16. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.
    Schalm SW; Heytink RA; van Buuren HR; de Man RA
    Lancet; 1985 Aug; 2(8451):358-60. PubMed ID: 2862516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
    Kay MH; Wyllie R; Deimler C; Caulfield M; Steffen R; Baetz-Greenwalt B
    J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A to F of viral hepatitis.
    Lancet; 1990 Nov; 336(8724):1158-60. PubMed ID: 1978030
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.
    Rodríguez-Iñigo E; Bartolomé J; López-Alcorocho JM; Contonat T; Oliva H; Carreño V
    J Med Virol; 1997 Sep; 53(1):76-80. PubMed ID: 9298736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.